ANGO vs BMRN · rev $292.5M vs P/E 40, rev $2.85B
AngioDynamics Inc (ANGO) versus Biomarin Pharmaceutical Inc (BMRN) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
ANGO currently screens at market cap $378.5M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Not investment advice. Open the ANGO and BMRN stock pages for the full models.
Not investment advice.